StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > news !

<< Previous

Bullboard Posts

Next >>

Comment by cactuseskimoon Mar 02, 2021 4:24pm

75 Views

Post# 32697816

RE:RE:RE:RE:RE:RE:RE:RE:news !

So, not sure what concrete conclusion you are drawing from this news Gladiator? I see that a new colorectal awareness and testing campaign is being launched, but I don't see any direct link with Stagezero in the material. Yes, we do have a colorectal cancer test, but we've not seen any significant revenue from it since it's introduction, so I wouldn't suddenly expect a massive uptick in revenue from this campaign. Obviously providers are using other solutions. The only link I see between the article that you linked and SZLS, is that they both state (in the article, and on the SZLS website) the phrase, "The best colorectal cancer test is the test that gets done". Interesting coincidence, but am I missing something? Thanks in advance!